A company called Gilead has come up with a drug called remdesivir which has shown some effect on covid-19 in trials.
The price for 1st world governments, including the U.S. Indian Health Services and the VA, is $2,340 for a 5-day course.
U.S. insurers, Medicare, and Medicaid, will pay $3,120. 3rd world a lot less through licensed generics.
That’s not too bad for a cure.
But it’s not a cure.
A 10 day treatment reduced the median recovery from 15 to 11 days.
Mortality with remdesivir was 7.1%, compared to 11.9% with a placebo.
The article says that’s not statistically significant??
In the less sick patient trial, remdesivir patients improved more than placebo if given for 5 days, but not when given for 10. What?
https://www.statnews.com/2020/06/29/...rice-covid-19/